Stock Rating Downgrade The Value Trend Rating for Ecolab Inc. (NYSE: ECL) weakened in recent days from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]
Stock Rating Downgrade In the last week the Value Trend Rating for Charles Schwab Corp (NYSE: SCHW) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Charles Schwab Corp […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Calix Inc (NYSE: CALX) weakened during the last several trading days. CALX’s current Value Trend Rating is D and the […]
Stock Rating Downgrade The Value Trend Rating for Amdocs Ltd (NASDAQ: DOX) weakened during the last several trading days from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating […]
Stock Rating Downgrade In the last week the Value Trend Rating for The LGL Group Inc (NYSEAMERICAN: LGL) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On 1/10/25, […]
Stock Rating Downgrade The Value Trend Rating for Superior Group of Cos Inc (NASDAQ: SGC) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Stryker Corp (NYSE: SYK) weakened in recent days. SYK’s current Value Trend Rating is D and the prior Rating was […]
Stock Rating Downgrade In the last week the Value Trend Rating for Optex Systems Holdings Inc (NASDAQ: OPXS) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Optex Systems […]
Stock Rating Downgrade The Value Trend Rating for OFS Capital Corporation (NASDAQ: OFS) weakened in recent days from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included […]
Intra-Cellular Therapies Inc (NASDAQ: ITCI) stock closed at $94.87 on 1/10/25 after a major increase of 14.9%. Moreover, exceptionally high trading volume at 687% of normal accompanied the advance. Relative to the market the stock […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research